OUTCOMES FOLLOWING HCT USING FLUDARABINE, BUSULFAN AND THYMOGLOBULIN: A MATCHED COMPARISON TO ALLOGENEIC TRANSPLANTS CONDITIONED WITH BUSULFAN AND CYCLOPHOSPHAMIDE

We have reported a lower incidence of acute graft versus host disease (aGVHD) with a novel conditioning regimen using low dose rabbit anti-thymocyte globulin (TG, Thymoglobulin) with fludarabine and intravenous busulfan (FluBuTG). To assess further this single center experience, we performed a retro...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bredeson, Christopher N., Zhang, Mei-Jie, Agovi, Manza-A., Bacigalupo, Andrea, Bahlis, Nizar J., Ballen, Karen, Brown, Christopher, Chaudhry, M. Ahsan, Horowitz, Mary M., Kurian, Seira, Quinlan, Diana, Muehlenbien, Catherine E., Russell, James A., Savoie, Lynn, Rizzo, J. Douglas, Stewart, Douglas A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3321981/
https://ncbi.nlm.nih.gov/pubmed/18721762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.06.009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky